Signe Møller-Bisgaard discusses her findings from the IMAGINE-RA study looking at the effects of adding the target of no osteitis or bone marrow edema on MRI to a conventional treat-to-target regimen in patients with RA (5:10).
15-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video